Why awareness matters
Prostate cancer is the second most common cancer in men globally. In many cases, it progresses slowly and may not cause symptoms in early stages — but not always. Some forms are aggressive and need early medical attention.
The challenge? The symptoms of prostate cancer often overlap with those of benign conditions like prostatitis or benign prostatic hyperplasia (BPH). Knowing what to watch for is a critical first step in protecting your health.
The prostate and its role
The prostate is a small, walnut-shaped gland located just below the bladder and in front of the rectum. It produces seminal fluid, which nourishes and transports sperm.
As men age, the prostate often enlarges, which can affect urination. While an enlarged prostate is not always a sign of cancer, persistent or unusual symptoms should not be ignored.
Common early symptoms of prostate cancer
Prostate cancer may not cause any symptoms at all in its early stages, but when it does, men often report:
- Frequent urination, especially at night
- Weak or interrupted urine flow
- Difficulty starting or stopping urination
- Pain or burning during urination or ejaculation
- Blood in urine or semen
- A feeling that the bladder is not completely empty
If the cancer has spread (metastasized), other symptoms may include bone pain (especially in the hips, spine, or ribs), weight loss, or fatigue.
Symptoms vs. other prostate conditions
It’s important to know that similar urinary symptoms can occur due to:
- Benign prostatic hyperplasia (BPH) – a non-cancerous enlargement of the prostate
- Prostatitis – inflammation or infection of the prostate
Only a medical evaluation, often including a PSA (prostate-specific antigen) blood test and digital rectal exam (DRE), can determine the cause.
Who is at risk?
Certain factors can increase the risk of prostate cancer:
- Age – Risk increases significantly after age 50
- Family history – Especially if a father or brother had it
- Race – Black men are at higher risk and often diagnosed at a younger age
- Diet – High consumption of red meat and low intake of vegetables may increase risk
- Genetics – BRCA1/2 mutations and other inherited genes may play a role
Understanding your personal risk can help guide when to begin screenings.
.png)
The role of screening
Routine screening is the best way to catch prostate cancer early — often before symptoms even appear.
Typical screening options include:
- PSA test – Measures prostate-specific antigen levels in the blood. Elevated levels can indicate prostate cancer or other conditions.
- Digital rectal exam (DRE) – A doctor manually examines the prostate for irregularities.
- MRI or biopsy – If initial tests suggest cancer, further imaging or tissue sampling may be necessary.
There is some debate about when and how often to screen. In general, screening discussions are recommended:
- Starting at age 50 for average-risk men
- At age 45 for high-risk men (e.g. African descent or strong family history)
- At age 40 for very high-risk individuals
Always talk with your doctor to tailor a screening plan to your needs.
Advances in treatment
If diagnosed early, prostate cancer is often highly treatable. Treatment options may include:
- Active surveillance – For slow-growing cancers that may never cause harm
- Surgery – To remove the prostate gland
- Radiation therapy – External beam or brachytherapy
- Hormone therapy – To reduce testosterone that fuels cancer growth
- Targeted or immunotherapies – For advanced or resistant cancers
The treatment path depends on the cancer’s grade, stage, and the patient’s overall health and preferences.
Mental and emotional impact
A prostate cancer diagnosis can be overwhelming. Many men experience anxiety, depression, or concern about sexual function, incontinence, or identity. Support is essential.
Talk with:
- A counselor
- A cancer support group
- Your partner or trusted friend
You don’t have to go through it alone — many resources are available to help navigate this chapter with strength and clarity.
Looking beyond today's options
Even with medical advancements, aggressive prostate cancer can sometimes progress despite the best available therapies. In such cases, individuals may wonder: could future technologies do more?
At Tomorrow.bio, we offer human cryopreservation — preserving individuals at ultra-low temperatures after legal death, with the hope that future medicine may one day make revival and treatment possible. It’s not a cure, and it’s not guaranteed — but it’s a conscious choice for those who want to preserve their chance at life beyond the reach of current science.
We’re here to answer questions with transparency, care, and respect.
About Tomorrow.bio
At Tomorrow.bio, we are dedicated to advancing the science of cryopreservation with the goal of giving people a second chance at life. As Europe’s leading human cryopreservation provider, we focus on rapid, high-quality standby, stabilization, and storage of terminal patients — preserving them until future medical technologies may allow revival and treatment.
Our mission is to make human cryopreservation a reliable and accessible option for everyone. We believe that no life should end because current medical capabilities fall short.
Our vision is a future where death is optional — where people have the freedom to choose long-term preservation in the face of terminal illness or fatal injury, and to awaken when medicine has caught up.
📧 Contact us at: hello@tomorrow.bio
🌐 Visit our website: www.tomorrow.bio
🤝 Schedule a call with our team: Book a call
